Unilever PLC (NYSE:UL) Shares Bought by Blue Barn Wealth LLC

Blue Barn Wealth LLC lifted its holdings in shares of Unilever PLC (NYSE:UL) by 8.0% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 5,373 shares of the company’s stock after acquiring an additional 398 shares during the period. Blue Barn Wealth LLC’s holdings in Unilever were worth $305,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of UL. Raymond James Financial Inc. acquired a new stake in shares of Unilever during the 4th quarter valued at $176,806,000. Jennison Associates LLC lifted its holdings in shares of Unilever by 981.6% during the 3rd quarter. Jennison Associates LLC now owns 2,076,169 shares of the company’s stock valued at $134,868,000 after buying an additional 1,884,216 shares during the last quarter. Fisher Asset Management LLC raised its holdings in shares of Unilever by 7.3% during the 4th quarter. Fisher Asset Management LLC now owns 17,940,963 shares of the company’s stock valued at $1,017,253,000 after purchasing an additional 1,214,563 shares in the last quarter. Citigroup Inc. lifted its position in shares of Unilever by 493.4% in the third quarter. Citigroup Inc. now owns 1,105,064 shares of the company’s stock worth $71,785,000 after buying an additional 918,841 shares during the last quarter. Finally, Icon Wealth Advisors LLC lifted its stake in shares of Unilever by 7,466.0% in the third quarter. Icon Wealth Advisors LLC now owns 629,569 shares of the company’s stock worth $40,897,000 after buying an additional 621,248 shares during the last quarter. Institutional investors and hedge funds own 9.67% of the company’s stock.

Unilever Stock Performance

NYSE:UL opened at $58.38 on Thursday. The company has a market capitalization of $144.85 billion, a PE ratio of 16.73, a P/E/G ratio of 1.60 and a beta of 0.47. Unilever PLC has a fifty-two week low of $46.46 and a fifty-two week high of $65.87. The company has a 50 day simple moving average of $56.64 and a two-hundred day simple moving average of $59.86.

Unilever Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 28th. Stockholders of record on Friday, February 28th will be issued a dividend of $0.4674 per share. The ex-dividend date of this dividend is Friday, February 28th. This represents a $1.87 annualized dividend and a dividend yield of 3.20%. Unilever’s dividend payout ratio is 53.01%.

Analyst Upgrades and Downgrades

UL has been the subject of a number of research reports. Sanford C. Bernstein upgraded Unilever from a “hold” rating to a “strong-buy” rating in a research report on Thursday, January 9th. Erste Group Bank reissued a “hold” rating on shares of Unilever in a report on Tuesday, November 19th. Royal Bank of Canada lowered shares of Unilever from a “sector perform” rating to an “underperform” rating in a research note on Monday, January 6th. DZ Bank upgraded Unilever from a “hold” rating to a “buy” rating in a research report on Friday, February 21st. Finally, StockNews.com downgraded Unilever from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Two research analysts have rated the stock with a sell rating, two have given a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $66.33.

Unilever Profile

Unilever PLC operates as a fast-moving consumer goods company in the Asia Pacific, Africa, the Americas, and Europe. It operates through five segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products consist of the vitamins, minerals, and supplements.